China's first homegrown antiviral helps relieve COVID-19 flare-ups

China's first homegrown COVID-19 antiviral, approved by the top drug regulator last month and added to the national COVID-19 treatment protocol this week, has been shipped to regions coping with virus flare-ups, according to drug developers.

Related Keywords

Pingshan ,Guangdong ,China ,Shanghai ,Hainan ,Pingdingshan ,Henan ,Beijing ,Peking ,Li Taisheng ,Xinjiang Uygur ,Chang Junbiao ,Fosun Pharma ,Zhengzhou University In Henan ,Union Pharmaceutical Factory ,National Healthcare Security Administration ,China Daily ,Union Medical College Hospital ,Genuine Biotech ,Beijing Union Pharmaceutical Factory ,Zhengzhou University ,Peking Union Medical College Hospital ,Drug ,Azvudine ,Covid 19 ,Virus ,Company ,Coral ,Patients ,Pill ,Province ,